THE SUPERIOR STUDY (on-going study)

SUPERIOR is a randomized clinical trial aiming to the early treatment with antimicrobials at the emergency department at the triage level of patients with one quick SOFA sign guided by the measurement of suPAR (soluble urokinase plasminogen activator receptor)

Study title: “A suPAR guided double-blind randomized clinical trial of initiation of antibiotics for presumed infection at the emergency department: THE SUPERIOR trial”
ClinicalTrials.gov NCT03717350
EudraCT number 2018-001008-13
National Organization for Medicines Approval: IS052/18
National Ethics Committee Approval: 46/18
Study phase: II
Study sites: 2 sites in Greece
Target of enrolment: 244 patients
Starting month: November 2018
Anticipated end month: December 2019